COMPASS PATHWAYS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
COMPASS PATHWAYS PLC (CMPS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.04 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2022-02-24
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2021-12-31 was 291.00K shares.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2021-09-30 was 440.50K shares.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 1.04M shares, a 69.35% decline from fiscal 2020.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 3.41M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2021-12-31 | 291.00K shares derived: 10-K 12 month − 6-K 9 month · filed 2022-02-24 | 731.50K shares derived: sum of 2 quarters · filed 2022-02-24 | 1.04M shares 10-K · filed 2022-02-24 | |
| 2021-09-30 | 440.50K shares derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | 752.70K shares 6-K · filed 2021-11-09 | ||
| 2021-06-30 | 312.20K shares 6-K · filed 2021-08-11 | |||
| 2020-12-31 | 3.41M shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |